Stem cell trial for critical COVID patients withdrawn before starting
Disease control
Terminated
This study aimed to test the safety and effects of an experimental stem cell treatment (BX-U001) for adults hospitalized with severe COVID-19 pneumonia and serious breathing problems (ARDS). The trial was designed in two parts: first to find a safe dose, and then to compare that …
Phase: PHASE1, PHASE2 • Sponsor: Baylx Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC